Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To compare standard treatment, low-dose Ara-C against the available novel approaches: •LD Ara-C combined with AC220 •LD Ara-C combined with Ganetespib •LD Ara-C combined with Tosedostat •LD Ara-C combined with Selinexor •Drug X During the course of the Programme other novel therapies (Drug X) are expected to become available, and will be considered for inclusion in this comparison.
Critère d'inclusion
- Acute myeloid leukemia and high-risk myelodysplastic syndrome